Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75.

Integrase (IN) is an essential retroviral enzyme, and human transcriptional coactivator p75, which is also referred to as lens epithelium-derived growth factor (LEDGF), is the dominant cellular binding partner of HIV-1 IN. Here, we report the crystal structure of the dimeric catalytic core domain of HIV-1 IN complexed to the IN-binding domain of LEDGF. Previously identified LEDGF hotspot residues anchor the protein to both monomers at the IN dimer interface. The principal structural features of IN that are recognized by the host factor are the backbone conformation of residues 168-171 from one monomer and a hydrophobic patch that is primarily comprised of alpha-helices 1 and 3 of the second IN monomer. Inspection of diverse retroviral primary and secondary sequence elements helps to explain the apparent lentiviral tropism of the LEDGF-IN interaction. Because the lethal phenotypes of HIV-1 mutant viruses unable to interact with LEDGF indicate that IN function is highly sensitive to perturbations of the structure around the LEDGF-binding site, we propose that small molecule inhibitors of the protein-protein interaction might similarly disrupt HIV-1 replication.

[1]  Myriam Witvrouw,et al.  Integrase Mutants Defective for Interaction with LEDGF/p75 Are Impaired in Chromosome Tethering and HIV-1 Replication* , 2005, Journal of Biological Chemistry.

[2]  A. Engelman,et al.  Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75 , 2005, Nature Structural &Molecular Biology.

[3]  R. Benarous,et al.  The Interaction of LEDGF/p75 with Integrase Is Lentivirus-specific and Promotes DNA Binding* , 2005, Journal of Biological Chemistry.

[4]  Maria Vanegas,et al.  Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering , 2005, Journal of Cell Science.

[5]  A. Engelman.  The ups and downs of gene expression and retroviral DNA integration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Llano,et al.  Lens Epithelium-derived Growth Factor/p75 Prevents Proteasomal Degradation of HIV-1 Integrase* , 2004, Journal of Biological Chemistry.

[7]  A. Engelman,et al.  Class II Integrase Mutants with Changes in Putative Nuclear Localization Signals Are Primarily Blocked at a Postnuclear Entry Step of Human Immunodeficiency Virus Type 1 Replication , 2004, Journal of Virology.

[8]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[9]  Pamela A. Silver,et al.  Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-derived Growth Factor/Transcriptional Co-activator p75 (LEDGF/p75) That Binds HIV-1 Integrase* , 2004, Journal of Biological Chemistry.

[10]  Pamela A Silver,et al.  Human cell proteins and human immunodeficiency virus DNA integration. , 2004, Frontiers in bioscience : a journal and virtual library.

[11]  M. Llano,et al.  LEDGF/p75 Determines Cellular Trafficking of Diverse Lentiviral but Not Murine Oncoretroviral Integrase Proteins and Is a Component of Functional Lentiviral Preintegration Complexes , 2004, Journal of Virology.

[12]  A. Engelman,et al.  Identification and Characterization of a Functional Nuclear Localization Signal in the HIV-1 Integrase Interactor LEDGF/p75* , 2004, Journal of Biological Chemistry.

[13]  Robert Craigie,et al.  Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[15]  F. Bushman.  Targeting Survival Integration Site Selection by Retroviruses and LTR-Retrotransposons , 2003, Cell.

[16]  E. De Clercq,et al.  LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells* , 2003, Journal of Biological Chemistry.

[17]  A. Aggarwal,et al.  RNA recognition via the SAM domain of Smaug. , 2003, Molecular cell.

[18]  Zeger Debyser,et al.  HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells* , 2003, The Journal of Biological Chemistry.

[19]  Wei Yang,et al.  Structure of a two‐domain fragment of HIV‐1 integrase: implications for domain organization in the intact protein , 2001, The EMBO journal.

[20]  M. Malim,et al.  HIV-1 infection requires a functional integrase NLS. , 2001, Molecular cell.

[21]  P Bork,et al.  Comparison of ARM and HEAT protein repeats. , 2001, Journal of molecular biology.

[22]  Tania A. Baker,et al.  Comparative architecture of transposase and integrase complexes , 2001, Nature Structural Biology.

[23]  F. Bushman,et al.  Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain. , 2001, Acta crystallographica. Section D, Biological crystallography.

[24]  P. Proost,et al.  High‐level expression of active HIV‐1 integrase from a synthetic gene in human cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  F. Bushman,et al.  Crystal structure of an active two-domain derivative of Rous sarcoma virus integrase. , 2000, Journal of molecular biology.

[26]  D. Hazuda,et al.  X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform. , 2000, Journal of molecular biology.

[27]  Merkel,et al.  Atomic Resolution Structures of the Core Domain of Avian Sarcoma Virus Integrase and Its D64N Mutant. , 1999, Biochemistry.

[28]  E. De Clercq,et al.  Nuclear localization of human immunodeficiency virus type 1 integrase expressed as a fusion protein with green fluorescent protein. , 1999, Virology.

[29]  O. Schwartz,et al.  Oligomerization within Virions and Subcellular Localization of Human Immunodeficiency Virus Type 1 Integrase , 1999, Journal of Virology.

[30]  K. Kohn,et al.  Chicoric acid analogues as HIV-1 integrase inhibitors. , 1999, Journal of medicinal chemistry.

[31]  Patrice Gouet,et al.  ESPript: analysis of multiple sequence alignments in PostScript , 1999, Bioinform..

[32]  C. Chothia,et al.  The atomic structure of protein-protein recognition sites. , 1999, Journal of molecular biology.

[33]  V. Mikol,et al.  Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases. , 1998, Journal of molecular biology.

[34]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[35]  D. Davies,et al.  Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Gronenborn,et al.  Solution structure of the N-terminal zinc binding domain of HIV-1 integrase , 1997, Nature Structural Biology.

[37]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[38]  M S Lewis,et al.  Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. , 1997, Biochemistry.

[39]  R. Craigie,et al.  Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  A. Engelman,et al.  A Soluble Active Mutant of HIV-1 Integrase , 1996, The Journal of Biological Chemistry.

[41]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[42]  Rolf Boelens,et al.  The DNA-binding domain of HIV-1 integrase has an SH3-like fold , 1995, Nature Structural Biology.

[43]  A M Gronenborn,et al.  Solution structure of the DNA binding domain of HIV-1 integrase. , 1995, Biochemistry.

[44]  D. Davies,et al.  Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  A. Engelman,et al.  Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. , 1994, Science.

[46]  A. Engelman,et al.  Biophysical and enzymatic properties of the catalytic domain of HIV-1 integrase. , 1994, The Journal of biological chemistry.

[47]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[48]  F. Bushman,et al.  Identification of discrete functional domains of HIV‐1 integrase and their organization within an active multimeric complex. , 1993, The EMBO journal.

[49]  F. Bushman,et al.  Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[50]  R. Plasterk,et al.  Identification of the catalytic and DNA-binding region of the human immunodeficiency virus type I integrase protein. , 1993, Nucleic acids research.

[51]  A. Engelman,et al.  Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro , 1992, Journal of virology.

[52]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[53]  Frank Petersen,et al.  Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex , 2004 .

[54]  Martyn D Winn,et al.  Macromolecular TLS refinement in REFMAC at moderate resolutions. , 2003, Methods in enzymology.

[55]  Alan M. Lambowitz,et al.  Mobile DNA III , 2002 .

[56]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.